Skip to main content
SpringerLink
Log in

Medical Treatment of Age-Related Osteoporosis: Present and Future

  • Chapter
Osteoporosis in Older Persons

  • 947 Accesses

The expected rise in 80-year-old and over men and women in populations throughout the world will increase the incidence of senile osteoporosis in the coming decades (1). The consequent rise in fractures may be even greater than currently predicted, as there is evidence to suggest that the rate of increase is greater than that accounted for by the demographic changes alone (2). Additionally, unlike younger age groups, where women are predominantly affected, men aged over 65 years are also at significantly increased risk of fracture (3). Osteoporotic fractures are associated with reduced quality of life and increased morbidity and mortality, particularly in the 80-year-old and over age group (4). Hip fractures, which are considered the most debilitating type of fracture with the greatest adverse economic impact, occur most frequently in this elderly population (5,6). Despite the contribution that fractures, particularly hip fractures, make to the public health burden, strategies for early diagnosis and appropriate treatment are not widely implemented in this age group; action is necessary to reverse the spiraling trend of increased fractures caused by the aging population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ettinger MP. Aging bone and osteoporosis: strategies for preventing fractures in the elderly. Arch Intern Med 2000;163:2237–2246.

    Article  Google Scholar 

  2. Palvanen M, Kannus S, Niemi S, et al. Secular trends in the osteoporotic fractures of the distal humerus in elderly women. Eur J Epidemiol 1998;14:159–164.

    Article  CAS  PubMed  Google Scholar 

  3. Colón-Emeric CS, Pieper CF, Artz MB. Can historical and functional risk factors be used to predict fractures in community-dwelling older adults? Development and validation of a clinical tool. Osteoporos Int 2002;13:955–961.

    Article  PubMed  Google Scholar 

  4. Melton LJ, Kan SH, Frye MA, et al. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989;129:1000–1011.

    PubMed  Google Scholar 

  5. Autier P, Haentjens P, Bentin J, et al. for the Belgium Hip Fracture Study Group. Costs induced by hip fractures: a prospective controlled study in Belgium. Osteoporos Int 2000;11:373–380.

    Article  CAS  PubMed  Google Scholar 

  6. Cooper C, Campion G, Melton LJ. Hip fracture in the elderly: a worldwide projection. Osteoporos Int 1992;2:285–289.

    Article  CAS  PubMed  Google Scholar 

  7. van der Meulen MC, Beaupe GS, Carter DR. Mech-anobiologic influences in long bone cross-sectional growth. Bone 1993;14:635–642.

    Article  PubMed  Google Scholar 

  8. Meunier PJ, Delmas PD, Eastell R, et al. International Committee for Osteoporosis Clinical Guidelines. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. Clin Ther 1999;21:1025–1044.

    Article  CAS  PubMed  Google Scholar 

  9. Bauer DC, Sklarin PM, Stone KL, et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteo-porotic fractures. J Bone Miner Res 1999;14:1404–1410.

    Article  CAS  PubMed  Google Scholar 

  10. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures: the Study of Osteoporotic Fractures Research Group. Lancet 1993;341:72–75.

    Article  CAS  PubMed  Google Scholar 

  11. Heaney RP. Is the paradigm shifting? Bone 2003;33:457–465.

    Article  PubMed  Google Scholar 

  12. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 1996;11:1531–1538.

    CAS  PubMed  Google Scholar 

  13. Mori S, Harruff R Ambrosius W, Burr DB. Tra-becular bone volume and microdamage accumulation in the femoral heads of women with and without femoral neck fractures. Bone 1997;21:521–526.

    Article  CAS  PubMed  Google Scholar 

  14. Ettinger B, Pressman A, Sklarin P, et al. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the Study of Osteoporotic Fractures. J Clin Endocrinol Metab 1998;83:2239–2243.

    Article  CAS  PubMed  Google Scholar 

  15. Cummings SR, Browner WS, Bauer D, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1998;339:733–738.

    Article  CAS  PubMed  Google Scholar 

  16. Stone K, Bauer DC, Black DM, et al. Hormonal predictors of bone loss in elderly women: a prospective study. J Bone Miner Res 1998;13:1167–1174.

    Article  CAS  PubMed  Google Scholar 

  17. Seeman E. Osteoporosis II: pathogenesis of bone fragility in women and men. Lancet 2002;359:1841–1850.

    Article  PubMed  Google Scholar 

  18. Lips P. Vitamin D deficiency and secondary hyper-parathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477–501.

    Article  CAS  PubMed  Google Scholar 

  19. Garraway WM, Stauffer RN, Kurland LT, et al. Limb fractures in a defined population II: ortho-pedic treatment and utilization of health care. Mayo Clin Proc 1979;54:708–713.

    CAS  PubMed  Google Scholar 

  20. Barrett JA, Baron JA, Beach ML. Mortality and pulmonary embolism after fracture in the elderly. Osteoporos Int 2003;14:889–894.

    Article  PubMed  Google Scholar 

  21. Kanis JA, Oden A, Johnell O, et al. The components of excess mortality after hip fracture. Bone 2003;32:468–473.

    Article  CAS  PubMed  Google Scholar 

  22. Eastell R, Reid DM, Compston J, et al. Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action. Q J Med 2001;94:575–597.

    CAS  Google Scholar 

  23. Boockvar KS, Halm EA, Litke A, et al. Hospital readmissions after hospital discharge for hip fracture: surgical and nonsurgical causes and effects on outcome. J Am Geriatr Soc 2003;51:300–403.

    Article  Google Scholar 

  24. Donaldson LJ, Cook A, Thompson RG. Incidence of fractures in a geographically defined population. J Epidemiol Community Health 1990;44:241–245.

    Article  CAS  PubMed  Google Scholar 

  25. Elffors I, Allander E, Kanis JA, et al. The variable incidence of hip fracture in Southern Europe: The MEDOS study. Osteoporos Int 1994;4:253–263.

    Article  CAS  PubMed  Google Scholar 

  26. Kanis JA, Johnell O, Oden A, et al. Risk of hip fracture according to the World Health Organization Criteria for Osteopenia and Osteoporosis. Bone 2000;27:585–590.

    Article  CAS  PubMed  Google Scholar 

  27. Johnell O, Gullberg B, Allander E, et al. The apparent incidence of hip fracture in Europe: a study of National Register sources. Osteoporos Int 1992;2:248–254.

    Article  Google Scholar 

  28. Walker-Bone K, Dennison E, Cooper C. Epidemiology of osteoporosis. Rheum Dis Clin North Amer 2001;27:1–18.

    Article  CAS  Google Scholar 

  29. European Prospective Osteoporosis Study (EPOS) Group. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2002;29:517–522.

    Google Scholar 

  30. Kenny A, Taxel P. Osteoporosis in older men. Clin Cornerstone 2000;2:45–51.

    Article  CAS  PubMed  Google Scholar 

  31. Scane SC, Sutcliffe AM, Francis RM. The sequelae of vertebral crush fractures in men. Osteoporos Int 1994;4:89–92.

    Article  CAS  PubMed  Google Scholar 

  32. Pluijm SMF, Tromp AM, Smit JH, et al. Consequences of vertebral deformities in older men and women. J Bone Miner Res 2000;15:1564–1572.

    Article  CAS  PubMed  Google Scholar 

  33. Kanis JA, Oden A, Johnell O, et al. Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 2004;15:108–112.

    Article  PubMed  Google Scholar 

  34. Kelsey JL, Browner WS, Seeley DG, et al. Risk factors for fractures of the distal forearm and proximal humerus. Am J Epidemiol 1992;135:477–489.

    CAS  PubMed  Google Scholar 

  35. Ismail AA, Pye SR, Cockerill WC, et al. Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 2002;13:565–571.

    Article  CAS  PubMed  Google Scholar 

  36. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7:439–443.

    Article  CAS  PubMed  Google Scholar 

  37. Heaney RP. Calcium in the prevention and treatment of osteoporosis. J Intern Med 1992;231:169–180.

    Article  CAS  PubMed  Google Scholar 

  38. Heaney RP. The importance of calcium intake for lifelong skeletal health. Calcif Tiss Int 2002;70:70–73.

    Article  CAS  Google Scholar 

  39. Heaney RP, Gallagher JC, Johnston CC, et al. Calcium nutrition and bone health in the elderly. Am J Clin Nutr 1982;36 (Suppl):986–1013.

    CAS  PubMed  Google Scholar 

  40. Ensrud KE, Duong T, Cauley JA, et al. Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Ann Intern Med 2000;132:345–353.

    CAS  PubMed  Google Scholar 

  41. Quesada JM, Coopmans W, Ruiz B, et al. Influence of vitamin D on parathyroid function in the elderly J Clin Endocrinol Metab 1992;75:494–501.

    Article  CAS  PubMed  Google Scholar 

  42. Boonen S, Broos P, Verbeke G, et al. Calciotropic hormones and markers of bone remodelling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperpara-thyroidism-induced bone resorption. J Gerontol A Biol Sci Med Sci 1997;52:M286–M293.

    CAS  PubMed  Google Scholar 

  43. Boonen S, Vanderschueren D, Cheng XG, et al. Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovi-taminosis D- and androgen deficiency-induced bone resorption. J Bone Miner Res 1997;12:2119–2126.

    Article  CAS  PubMed  Google Scholar 

  44. Garnero P, Sornay-Rendu E, Claustrat B, et al. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmeno-pausal women: the OFELY study. J Bone Miner Res 2000;15:1526–1536.

    Article  CAS  PubMed  Google Scholar 

  45. Bischoff HA, Stahelin HB, Urscheler N, et al. Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 1999;80:54–58.

    Article  CAS  PubMed  Google Scholar 

  46. Sorensen OH, Lund B, Saltin B, et al. Myopathy in bone loss of ageing: improvement by treatment with 1-alpha-hydroxy cholecalciferol and calcium. Clin Sci (Lond) 1979;56:157–161.

    CAS  Google Scholar 

  47. Gerdhem P, Ringsberg KA, Obrant KJ, et al. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int 2005;16:1425–1431.

    Article  CAS  PubMed  Google Scholar 

  48. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001;86:1212–1221.

    Article  CAS  PubMed  Google Scholar 

  49. Brazier M, Kamel S, Maamer M, et al. Markers of bone remodelling in the elderly subject: effects of vitamin D insufficiency and its correction. J Bone Miner Res 1995;10:1753–1761.

    CAS  PubMed  Google Scholar 

  50. Dawson-Hughes B, Harris SS, Krall EA, et al. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995;61:1140–1145.

    CAS  PubMed  Google Scholar 

  51. Malabanan A, Veronikis IE, Holick MF. Redefin-ing vitamin D insufficiency. Lancet 1998;351:805–806.

    Article  CAS  PubMed  Google Scholar 

  52. McKane WR, Khosla S, Egan KS, et al. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metal 1996;81:1699–1703.

    Article  CAS  Google Scholar 

  53. Ooms ME, Roos JC, Bezemer PD, et al. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995;80:1052–1058.

    Article  CAS  PubMed  Google Scholar 

  54. Grados F, Brazier M, Kamel S, et al. Prediction of bone mass density variation by bone remodelling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation. J Clin Endocrinol Metab 2003;88:5175–5179.

    Article  CAS  PubMed  Google Scholar 

  55. Lips P, Wiersinga A, van Ginkel FC, et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67:644–650.

    Article  CAS  PubMed  Google Scholar 

  56. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343–351.

    Article  CAS  PubMed  Google Scholar 

  57. Flicker L Macinnis RJ, Stein MS, et al. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 2005;53:1881–1888.

    Article  PubMed  Google Scholar 

  58. Porthouse J, Cockayne C, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005;330:1003–1008.

    Article  CAS  PubMed  Google Scholar 

  59. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999–2006.

    Article  CAS  PubMed  Google Scholar 

  60. Harwood RH, Sahota O, Gaynor K, et al. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: the Nottingham Neck of Femur (NoNOF) Study. Age Ageing 2004;33:45–51.

    Article  PubMed  Google Scholar 

  61. Adams JS, Kantorovich V, Wu C, et al. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab 1999;84:2729–2730.

    Article  CAS  PubMed  Google Scholar 

  62. Chapuy MC, Arlot ME, Duboeuf, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637–1642.

    CAS  PubMed  Google Scholar 

  63. Prestwood KM, Pannullo AM, Kenny AM, et al. The effect of a short course of calcium and vitamin D on bone turnover in older women. Osteoporos Int 1996;6:314–319.

    Article  CAS  PubMed  Google Scholar 

  64. Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002;13:257–264.

    Article  CAS  PubMed  Google Scholar 

  65. Chapuy MC, Arlot ME, Delmas PD, et al. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994;308:1081–1082.

    CAS  PubMed  Google Scholar 

  66. Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670–676.

    Article  CAS  PubMed  Google Scholar 

  67. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004;19:370–378.

    Article  CAS  PubMed  Google Scholar 

  68. The RECORD Trial Group. Oral vitamin D and calcium for secondary prevention of low-trauma fractures in elderly people: a randomised placebo-controlled trial. Lancet 2005;365:1621–1628.

    Article  CAS  Google Scholar 

  69. Boonen S, Vanderschueren D, Haentjens P, et al. Calcium and vitamin D in the prevention and treatment of osteoporosis—a clinical update. J Int Med 2006;259:539–552.

    Article  CAS  Google Scholar 

  70. Boonen S, Bischoff-Ferrari A, Cooper C, et al. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int 2006;78:257–270.

    Article  CAS  PubMed  Google Scholar 

  71. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both actuve and inactive persons aged 5≥60 y. Am J Clin Nutr 2004:80;752–758.

    CAS  PubMed  Google Scholar 

  72. Yates AA, Schlicker SA, Suitor CW. Dietary reference intakes: the new basis for recommendations for calcium and related nutrients, B vitamins and choline. J Am Diet Assoc 1998;98:699–706.

    Article  CAS  PubMed  Google Scholar 

  73. European Commission. Report on osteoporosis in the European community—action for prevention. http://www.osteofound.org/publications/pdf/eu_ report_98.pdf, 1998, date accessed: 9/5/2006.

  74. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials JAMA 2005;294:2257–2264.

    Article  Google Scholar 

  75. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669–683.

    Article  CAS  PubMed  Google Scholar 

  76. Lips P, Graafmans WC, Ooms ME, et al. Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med 1996;124:400–406.

    CAS  PubMed  Google Scholar 

  77. Gillespie WJ, Avenell A, Henry DA, et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2001;(1):CD000227.

    Google Scholar 

  78. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2007;92:1415–1423.

    Article  CAS  PubMed  Google Scholar 

  79. Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. Am J Clin Nutr 2000;72:745–750.

    CAS  PubMed  Google Scholar 

  80. Boonen S, McClung MR, Eastell R, et al. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Amer Geriatr Soc 2004;52:1832–1839.

    Article  Google Scholar 

  81. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278–285.

    CAS  PubMed  Google Scholar 

  82. Harris ST, Watts NB, Genant HK, et al. for the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomised controlled trial. JAMA 1999;282:1344–1352.

    Article  CAS  PubMed  Google Scholar 

  83. Reginster J, Minne HW, Sorensen OH, et al. on behalf of the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83–91.

    Article  CAS  PubMed  Google Scholar 

  84. McClung MR, Guesens P, Miller PD, et al. for the Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333–340.

    Article  CAS  PubMed  Google Scholar 

  85. Eastell R, Barton I, Hannon RA, et al. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 2003;18:1051–1056.

    Article  CAS  PubMed  Google Scholar 

  86. Hochberg MC, Thompson DE, Black DM, et al. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res 2005;20:971–976.

    Article  CAS  PubMed  Google Scholar 

  87. Tonino RP, Meunier PJ, Emkey R, et al. Skeletal benefits of alendronate: 7-year treatment of post-menopausal osteoporotic women. J Clin Endocri-nol Metab 2000;85:3109–3115.

    Article  CAS  Google Scholar 

  88. Lindsay R, Hart D, Clark D. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984;63:759–763.

    CAS  PubMed  Google Scholar 

  89. Stevenson J, Cuat M, Gangar K, et al. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet 1990;335:265–269.

    Article  Google Scholar 

  90. Heaney R. Estrogen-calcium interactions in the postmenopause: a quantitative description. Bone Miner 1990;11:67–84.

    Article  CAS  PubMed  Google Scholar 

  91. Felso D, Zhang Y, Hannan M, et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141–1146.

    Article  Google Scholar 

  92. Weiss N, Ure C, Ballard J, et al. Decreased risk of fractures of the hip and lower forearm with post-menopausal use of estrogen. N Engl J Med 1980;303:1195–1198.

    Article  CAS  PubMed  Google Scholar 

  93. Paganini-Hill A, Ross R, Gerkins V, et al. Meno-pausal estrogen therapy and hip fractures. Ann Intern Med 1981;95:28–31.

    CAS  PubMed  Google Scholar 

  94. Kiel D, Felson D, Anderson J, et al. Hip fracture and the use of estrogens in postmenopausal women—The Framingham Study. N Engl J Med 1987;317:1169–1174.

    Article  CAS  PubMed  Google Scholar 

  95. Cauley JA, Seeley DG, Ensrud K, et al. Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995;122:9–16.

    CAS  PubMed  Google Scholar 

  96. Michaëlsson K, Baron JA, Farahmand BY, et al. Hormone replacement therapy and risk of hip fracture: population based case-control study. Br Med J 1998;316:1858–1863.

    Google Scholar 

  97. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA 2001;285:2891–2897.

    Article  CAS  PubMed  Google Scholar 

  98. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999;282:637–645.

    Article  CAS  PubMed  Google Scholar 

  99. Delmas PD, Genant HK, Crans GG, et al. Severity of prevalent fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 2003;33:522–532.

    Article  CAS  PubMed  Google Scholar 

  100. Lindsay R, Nieves J, Formica C, et al. Randomized controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 1997;350:550–555.

    Article  CAS  PubMed  Google Scholar 

  101. Dempster DW, Cosman F, Parisien M, et al. Anabolic actions of parathyroid hormone on bone. Endocr Rev 1993;14:690–709.

    CAS  PubMed  Google Scholar 

  102. Marcus R, Wang O, Satterwhite J, et al. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res 2003;18:18–23.

    Article  CAS  PubMed  Google Scholar 

  103. Boonen S J, Marin F, Mellstrom D, et al. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. J Am Geriatri Soc 2006;54:782–789.

    Article  Google Scholar 

  104. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998;338:736–746.

    Article  CAS  PubMed  Google Scholar 

  105. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New Engl J Med 2001;344:1434–1441.

    Article  CAS  PubMed  Google Scholar 

  106. Marie PJ. Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate. Osteoporos Int 2003;14 (Suppl 3):S9–S12.

    CAS  PubMed  Google Scholar 

  107. Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004;350:459–468.

    Article  CAS  PubMed  Google Scholar 

  108. Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of non vertebral fractures in postmenopausal women with osteoporosis: Treatment Of Peripheral Osteoporosis (TROPOS) Study. Endocrinol Metab 2005;90:2816–2822.

    Article  CAS  Google Scholar 

  109. Reginster JY, Meunier PJ, Roux C, et al. Strontium ranelate: an anti-osteoporotic treatment demonstrated vertebral and nonvertebral anti-fracture efficacy over 5 years in post-menopausal osteopo-rotic women. Osteoporos Int 2006;17 (Suppl 2): S14(OC24).

    Article  CAS  Google Scholar 

  110. Seeman E, Vellas B, Benhamou CL, et al. Strontium ranelate reduces the risk of vertebral and non-vertebral fractures in women aged eighty years and over. J Bone Miner Res 2006;21:1113–1120.

    Article  CAS  PubMed  Google Scholar 

  111. Seeman E, Vellas B, Benhamou CL, et al. Sustained 5-year vertebral and non-vertebral fracture risk reduction with strontium ranelate in elderly women with osteoporosis. Osteoporos Int 2006;18:1–13(OC39).

    Google Scholar 

  112. Gourlay M, Richy F, Reginster JY. Strategies for the prevention of hip fracture. Am J Med 2003;115:309–317.

    Article  PubMed  Google Scholar 

  113. Lee SH, Dargent-Molina P, Bréart G, for the EPIDOS Group. Risk factors for fractures of the proximal humerus: results from the EPIDOS prospective study. J Bone Miner Res 2002;17:817–825.

    Article  PubMed  Google Scholar 

  114. Cadarette SM, Jaglal SB, Kreiger N, et al. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. Can Med Assoc J 2000;162:1289–1294.

    CAS  Google Scholar 

  115. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Fall Prevention. Guideline for the prevention of falls in older persons. J Am Geriatr Soc 2001;49:664–672.

    Article  Google Scholar 

  116. Close JC, McMurdo ME on behalf of the British Geriatrics Society Falls and Bone Health Section. Falls and bone health services for older people. Age Ageing 2003;32:494–496.

    Article  PubMed  Google Scholar 

  117. Briancon D, de Gaudemar JB, Forestier R. Management of osteoporosis in women with peripheral osteoporotic fractures after 50 years of age: a study of practices. Joint Bone Spine 2004;71:128–130.

    Article  PubMed  Google Scholar 

  118. Feldstein A, Elmer PJ, Orwoll E, et al. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures. Arch Intern Med 2003;163:2165–2172.

    Article  PubMed  Google Scholar 

  119. Birge SJ, Morrow-Howell N, Proctor EK. Hip fracture. Clin Geriatr Med 1994;10:589–609.

    CAS  PubMed  Google Scholar 

  120. Sheehan J, Mohamed F, Reilly M, Perry IJ. Secondary prevention following fractured neck of femur: a survey of orthopaedic surgeons practice. Irish Med J 2000;93:105–107.

    CAS  Google Scholar 

  121. Feldstein AC, Nichols GA, Elmer PJ, et al. Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am 2003;85-A:2294–2302.

    PubMed  Google Scholar 

  122. Poole KE, Reeve J, Warburton EA. Falls, fractures, and osteoporosis after stroke. Time to think about protection? Stroke 2002;33:1432–1436.

    Article  PubMed  Google Scholar 

  123. Kamel HK, Hussain MS, Tariq S, et al. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 2000;109:326–328.

    Article  CAS  PubMed  Google Scholar 

  124. Bahl S, Coates PS, Greenspan SL. The management of osteoporosis following hip fracture: have we improved our care? Osteoporos Int 2003;14:884–888.

    Article  PubMed  Google Scholar 

  125. Cummings SR, Nevitt MC. Falls. N Engl J Med 1994;331;87,873.

    Article  Google Scholar 

  126. Greenspan SL, Myers ER, Maitland LA, et al. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA 1994;271:128–133.

    Article  CAS  PubMed  Google Scholar 

  127. Greenspan SL, Myers ER, Kiel DP, et al. Fall direction, bone mineral density, and function: Risk factors for hip fracture in frail nursing home elderly. Am J Med 1998;104:539–545.

    Article  CAS  PubMed  Google Scholar 

  128. Stone KL, Seeley DG, Lui L-Y, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 2003;18:1947–1954.

    Article  PubMed  Google Scholar 

  129. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254–1259.

    CAS  PubMed  Google Scholar 

  130. Cummings SR, Nevitt MC, Browner WS, et al., The Study of Osteoporotic Fractures Research Group. Risk factors for hip fractures in white women. N Engl J Med 1995;332:767–773.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Leuven University Center for Metabolic Bone Diseases and Division of Geriatric Medicine, Katholieke Universiteit Leuven, Leuven, Belgium

    Steven Boonen MD, PhD (Professor of Medicine)

Authors
  1. Steven Boonen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Geriatric Medicine-Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada

    Gustavo Duque

  2. Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, USA

    Douglas P. Kiel

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Boonen, S. (2009). Medical Treatment of Age-Related Osteoporosis: Present and Future. In: Duque, G., Kiel, D.P. (eds) Osteoporosis in Older Persons. Springer, London. https://doi.org/10.1007/978-1-84628-697-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-697-1_11

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-515-8

  • Online ISBN: 978-1-84628-697-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation